医療大麻市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00022901
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 181
Buy Now

医療用マリファナ市場は、2021 年に 117 億 650 万米ドルと評価され、2028 年までに 400 億 2759 万米ドルに達する可能性があります。 2022 年から 2028 年にかけて 19.2% の CAGR で成長すると推定されています。



医療大麻としても知られる医療用マリファナは、治療分野での応用が増加しているため、日々人気を集めています。大麻サティバ植物に由来し、慢性疾患の治療や疼痛管理に使用できます。



医療用マリファナ市場は、製品、アプリケーション、流通チャネル、地理に分割されています。地理的に、市場は北米、ヨーロッパ、アジア太平洋、中東とアフリカ、南アメリカと中央アメリカに広く分割されています。このレポートは、市場の動向やダイナミクス、世界をリードする市場プレーヤーの競争分析などのパラメーターに重点を置いて、市場の洞察と詳細な分析を提供します。



戦略的洞察



医療用マリファナ市場の有利な地域



市場の洞察



医療用マリファナ製品の承認の増加



マリファナの医学的可能性は、さまざまな研究者や企業を引き付けて、マリファナを医療用途に使用しています.たとえば、テトラヒドロカンナビノール (THC) は主に医薬品の製造に使用されます。米国食品医薬品局 (FDA) は、有効成分としてナボリンを含むセサメットなどの THC ベースの医薬品を承認しました。これは、THC に類似した構造を持つ合成由来の製品です。セサメットは、化学療法を受けている患者の吐き気の治療のために処方されています。セサメットは一般的に、吐き気や嘔吐を他の薬でコントロールできない場合に処方されます。 FDA はまた、米国でマリノールと Syndros の治療用途を承認しました。マリノールとシンドロスには、大麻の精神活性成分と考えられている合成 9-THC である有効成分のドロナビノールが含まれています。マリノールと Syndros 薬は、AIDS の徴候の 1 つとして開発された消耗症候群の患者の食欲を刺激するために処方されます。同様に、さまざまなマリファナベースの製品が承認されているか、臨床試験が行われています.たとえば、ナビキシモルス (サティベックス) は、カナダで商品化された承認済みの医薬品です。ナビキシモルスは、多発性硬化症に関連する痙性および神経因性疼痛の治療に使用される大麻抽出物です。 THCと他のカンナビジオール(CBD)の組み合わせで処方されています。 2020 年 2 月、カナダの会社である CanaQuest Medical Corp は、メンタビノールの製造と商品化の承認をカナダ保健省に申請しました。メンタビノールはTHCベースの製品であり、その承認申請は大麻法に基づいて提出されています. FDAによる上記のマリファナベースの製品の承認の増加は、医療用マリファナ市場の成長を牽引しています.



製品ベースの洞察



製品に基づいて、医療用マリファナ市場は乾燥形態と抽出形態に分かれています。抽出フォーム セグメントは、2021 年に大きな市場シェアを保持しました。さらに、同じセグメントは、予測期間中に 19.3% の高い CAGR を登録すると予想されます。抽出形態セグメントの成長は、医療用途における液体抽出物の需要の高まり、自然健康製品の消費による健康とウェルネスの傾向の増加、および乾燥マリファナに対する抽出物の利点に関する意識の高まりに起因する可能性があります.



医療用マリファナ市場、製品別 - 2021 年および 2028 年



アプリケーション ベースの洞察



アプリケーションに基づいて、医療用マリファナ市場は疼痛管理、トゥレット症候群、アルツハイマー病に分割されます、片頭痛、うつ病と不安神経症、多発性硬化症、癌など。疼痛管理セグメントは、2021 年に最大の市場シェアを保持しました。しかし、多発性硬化症セグメントは、2022 年から 2028 年にかけて 20.3% という最速の CAGR を記録すると予想されます。疼痛管理セグメントは、外傷または高血圧の有病率の増加に牽引され、需要が増加しています。



流通チャネルに基づく洞察



流通チャネルに基づいて、医療用マリファナ市場は次のように分割されます。小売薬局、電子商取引など。小売薬局セグメントは、2021 年に最大の市場シェアを保持しました。ただし、e コマース セグメントは、2022 年から 2028 年の間に 19.8% という最速の CAGR を記録すると予想されます。小売薬局セグメントの主な推進要因は、高度に規制されたサプライ チェーン、専門家によるコンサルティング、および遵守を向上させる患者向けソリューションです。



製品の発売や承認などの有機的な開発は、医療用マリファナ市場。最近の主要な市場動向のいくつかを以下に示します。



2021 年 2 月、CANAQUEST MEDICAL CORP は、PurCann Pharma (「PurCann」) および SiliCycle Inc. (「SiliCycle」) との新しい製造販売契約を発表しました。 ;))。この契約により、CanaQuest の完全子会社である ADC BioMedical Corp. を通じて、CanaQuest が計画しているメンタニンおよびメンタビノール製剤の生産、流通、および世界的な輸出が促進されます。



会社概要



  • Aphria, Inc

  • Canopy Growth Corporation

  • CanaQuest Medical Corporation

  • GW Pharmaceuticals

  • Organigram Holdings Inc.

  • VIVO Cannabis Inc.

  • Panaxia Pharmaceutical Industries Ltd.

  • Phoena Holdings Inc.

  • Emerald Health Therapeutics Inc.

  • MARICANN INC.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the Medical Marijuana market?

Medical marijuana is a term for derivatives of the Cannabis sativa plant that are used to ease symptoms caused by certain medical conditions. Medical marijuana is also known as medical cannabis. Cannabis sativa contains many active compounds. The best known are delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary ingredient in marijuana. Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions. It's basically the same product as recreational marijuana, but it's taken for medical purposes.

Who are the major players in the medical marijuana market?

The medical marijuana market majorly consists of the players such as Aphria, Inc.; Canopy Growth Corporation; CanaQuest Medical Corporation; GW Pharmaceuticals; Organigram Holdings Inc.; VIVO Cannabis Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; Emerald Health Therapeutics Inc.; and MARICANN INC.

What are the driving factors for the medical marijuana market across the country?

The factors that are driving and restraining factors that will affect the medical marijuana market in the coming years. Factors such as increasing approvals of medical marijuana products and rising acceptance of medicinal use of marijuana in America. However, the illegal use of cannabis as a street drug and misconceptions regarding marijuana is likely to have a negative impact on the growth of the market in the coming years.

Which segment is dominating the medical marijuana market?

The global medical marijuana market based on product is dried form and extract form. The extract form segment is likely to hold the largest share of the market in 2022. Moreover, the segment is anticipated to register the highest CAGR in the market during the forecast period.

The List of Companies - Medical Marijuana Market

  1. Aphria, Inc.
  2. Canopy Growth Corporation
  3. CanaQuest Medical Corporation
  4. GW Pharmaceuticals
  5. Organigram Holdings Inc.
  6. VIVO Cannabis Inc
  7. Panaxia Pharmaceutical Industries Ltd.
  8. Phoena Holdings Inc.
  9. Emerald Health Therapeutics Inc.
  10. MARICANN INC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports